The Stafford Fox Rare Cancer Program (SFRCP)

GROUP Rare Cancers
PROJECT SPAN 2022
DATE 02/05/2022

The Stafford Fox Rare Cancer Program (SFRCP)

The Walter Eliza Hall Institute (WEHI) of Medical Research Stafford Fox Rare Cancer Program is a basic and translational research program for all rare cancers.

More information

It is based at the WEHI and is accessible through participating tertiary hospitals or via the ARC Portal. The SFRCP has internal research projects but can also help to facilitate external rare cancer research with access to clinically annotated rare cancer biospecimens.

Examples of projects supported by the SFRCP include:

Identification of novel drivers in patients with multiple rare cancers
Next generation sequencing of rare gynaecological malignancies
Understanding the distinct biology of gynaecological carcinosarcomas
Immunology and genomics of rare cancer super-responders
Novel therapies for high grade serous endometrial carcinomas
Uterine Leiomyosarcoma – genomics, pre-clinical models and therapeutics
Studies into ovarian sex-cord stromal tumours

wehi.edu.au/research-diseases/cancer/rare-cancers

Related projects

Rare Cancers

The Australian Genomic Cancer Medicine Centre (AGCMC) and Molecular Screening and Therapeutics (MoST)

Rare Cancers

The Australian Rare Cancer (ARC) Portal

Join Australia's leading oncology community & make an impact

Become a COSA member

Twitter
@COSAoncology

COSAoncology 13 hours ago

COSA's Nutrition Group Speed Networking Event is on Fri 25 July. COSA members, here's your chance to meet leading dietitians & researchers Jane Stewart, Merran Findlay & Emily Jeffery and connect with others interested in nutrition and cancer! Register at bit.ly/4nmK8GU

COSAoncology yesterday

Thank you @POCOG1 for maintaining Affiliated membership with COSA. PoCoG members get a discount for COSA membership, and might be interested in attending COSA-IPOS 2025 – COSA members also make a saving on registration! bit.ly/3hXsDLm

COSAoncology 2 days ago

COSA is pleased to endorse the Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations. bit.ly/44JLN0A Read the endorsement paper from @DrNicolasHart and his co-authors at bit.ly/3GINjIi

COSAoncology 3 days ago

We are pleased that @MOGA_ORG continue to be an Affiliated member organisation with COSA, and look forward to our ongoing collaboration to improve cancer care and control.MOGA provided their Marryalyan Report for COSA’s June eNews: bit.ly/4kpHz3V

COSAoncology 7 days ago

Thank you again to @RANZCRcollege for continuing your COSA Affiliated membership. RANZCR members are reminded to take advantage of the Affiliated discount for COSA memberships: bit.ly/3s5mOC6

COSAoncology 9 days ago

Thanks to @ESSA_NEWS for renewing as a COSA Associated organisation and continuing to collaborate with COSA. A reminder that ESSA members are invited to take advantage of discounted COSA membership: bit.ly/3s5mOC6

COSAoncology 16 days ago

Our Nutrition Group is hosting a Speed Networking Event on Fri 25 July for COSA members to get to know leading dietitians and researchers including Jane Stewart, Merran Findlay & Emily Jeffery. Connect with COSA members interested in nutrition and cancer! bit.ly/4nmK8GU

COSAoncology 17 days ago

The Tom Reeve Award recognises a national leader who's made significant contributions to cancer care. The award will be presented at COSA-IPOS 2025 in Adelaide in November where the recipient is invited to deliver an address. Nominations closing 14 July. bit.ly/3hIXWcV

COSAoncology 21 days ago

Have you renewed your COSA membership yet? You might like to renew before 30 June 2025: bit.ly/4cI0nc3

COSAoncology 23 days ago

Our June member newsletter is out now. Check your inbox for the latest COSA news and updates including new resources, events, opportunities and peer-reviewed journal articles. Or log in and view it online anytime at bit.ly/4kRIRpp